Sarah Verhoeff

118 Chapter 6 A Figure 2. Pathological assessment of response to neo-adjuvant avelumab Panel A shows patient characteristics regarding sex, histologic subtype, smoking, LN metastases (histological confirmed). Panel B shows a waterfall plot shows the pathological response, according to the remaining viable tumor cells for each of the 18 patients that underwent resection after neo-adjuvant avelumab treatment. The gray horizontal line indicates the threshold for major pathological response (90% regression). Clinical and pathological features are annotated for each patient. B